Revenue
2017
2018
2019
2020
2021
2022
Imunon, Inc. (IMNN)
Price—Loading quote
Net income
2018
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2018
2019
2020
2021
2022
2023
2024
2025
Total cash / debt
CashTotal debt
2018
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | $500,000 | $500,000 | $500,000 | $500,000 | $500,000 | $500,000 | — | — | — | — | — | — | — |
| Research & development | $7.8M | $11.6M | $11.3M | $11.7M | $10.6M | $11.3M | $13.1M | $11.9M | $13.1M | $14.6M | $14.7M | $15.0M | $9.4M | $15.8M | $19.9M | $14.7M |
| Operating expenses | $14.7M | $19.1M | $21.0M | $25.4M | $21.5M | $19.0M | $21.1M | $21.6M | $19.0M | $21.1M | $21.3M | $25.2M | $15.9M | $22.1M | $25.0M | $19.6M |
| Operating income | −$14.7M | −$19.1M | −$21.0M | −$24.9M | −$21.0M | −$18.5M | −$20.6M | −$21.1M | −$18.5M | −$20.6M | −$20.8M | −$24.7M | −$15.4M | −$22.1M | −$23.0M | −$19.6M |
| EBITDAderived | — | −$18.9M | −$20.8M | −$24.2M | −$20.3M | −$17.7M | −$19.8M | −$20.7M | −$17.9M | −$19.6M | −$20.4M | −$24.3M | −$15.1M | −$21.9M | −$22.8M | −$19.5M |
| Net income | −$14.5M | −$18.6M | −$19.5M | −$35.9M | −$20.8M | −$21.5M | −$16.9M | −$11.9M | −$20.4M | −$22.1M | −$22.5M | −$25.5M | −$8.3M | −$26.6M | −$23.2M | −$18.8M |
| Basic EPSper diluted share | -$6.83 | -$16.94 | -$2.16 | -$5.03 | -$3.83 | -$10.08 | -$0.77 | -$0.68 | -$2.72 | -$11.89 | -$1.03 | -$1.38 | -$0.95 | -$3.44 | -$5.00 | -$1.52 |
| Diluted EPSper diluted share | -$6.83 | -$16.94 | -$2.16 | -$5.03 | -$3.83 | -$10.08 | -$0.77 | -$0.68 | -$2.72 | -$11.89 | -$1.03 | -$1.38 | -$0.95 | -$3.44 | -$5.00 | -$1.52 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jun 29, 2026Form 4 | Eylward SusanGeneral Counsel and Corp Sec | SellCommon Stock | 11.8K | $1.75 | $20.6K | 2.9K |
| Aug 20, 2024Form 4 | Braun Donald PDirector | BuyCommon Stock | 25.0K | $1.18 | $29.5K | 25.6K |
| Aug 15, 2024Form 4 | Lindborg StacyPresident and CEO | BuyImunon Common Stock | 25.0K | $0.98 | $24.5K | 264.2K |
| Aug 15, 2024Form 4 | Tardugno Michael HExecutive Chairman of Board | BuyImunon Common Stock | 25.0K | $1.03 | $25.8K | 353.3K |